Amyloid Precursor Protein Revisited
The DOI matches its Crossref record, with a small difference in title or year; 3 of the 3 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In rodent brains, APP is expressed predominantly by neurons, rather than astrocytes, glial cells or microglia”
From Advances in the cell biology of the trafficking and processing of amyloid precursor protein: impact of familial Alzheimer's disease mutations (2024) · cites this paper as [71]
In the citing paper
“very little APP is detected in the lysosomes”
From Advances in the cell biology of the trafficking and processing of amyloid precursor protein: impact of familial Alzheimer's disease mutations (2024) · cites this paper as [71]
In the citing paper
“somatic APP resides predominantly in the Golgi and early or late endosomes in neurons”
From Advances in the cell biology of the trafficking and processing of amyloid precursor protein: impact of familial Alzheimer's disease mutations (2024) · cites this paper as [71]
In the citing paper
“The Epitomics and APP “Jonas” C-terminal antibodies were used for C-terminal staining, as the Epitomics antibody has been previously characterized (Guo et al., 2012), and the Jonas antibody showed both a decrease in vesicle intensity and number in APP knockout neurons (Supplemental Figure S3B).”
From Axonal amyloid precursor protein and its fragments undergo somatodendritic endocytosis and processing (2015) · cites this paper as Guo et al., 2012
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: APP binds DR6 to trigger axon pruning and neuron death via distinct caspases
Nikolaev, A., McLaughlin, T., O’Leary, D. D. M., & Tessier-Lavigne, M. (2009) · Nature · doi:10.1038/nature07767 · Cited by 992
RetractedGuo, Q., Fu, W., Sopher, B. L., Miller, M. W., Ware, C. B., Martin, G. M., & Mattson, M. P. (1999) · Nature Medicine · doi:10.1038/4789 · Cited by 489
Self-citationPierce, J., Trojanowski, J., Graham, D., Smith, D., & McIntosh, T. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-03-01083.1996 · Cited by 239 · cited 2×
“The punctate APP staining following TBI is likely due to its accumulation in the damaged neuronal axons (14, 15).”
Background
Research works printed but not linked: 46
- Zheng, 2011, Biology and pathophysiology of the amyloid precursor protein, Mol. Neurodegener., 6, 27, 10.1186/1750-1326-6-27 · DOI · Paper page
- Chauvet, 1997, Mab22C11 antibody to amyloid precursor protein recognizes a protein associated with specific astroglial cells of the rat central nervous system characterized by their capacity to support axonal outgrowth, J. Comp. Neurol., 377, 550, 10.1002/(SICI)1096-9861(19970127)377:4<550::AID-CNE6>3.0.CO;2-1 · DOI
- LeBlanc, 1997, Processing of amyloid precursor protein in human primary neuron and astrocyte cultures, J. Neurochem., 68, 1183, 10.1046/j.1471-4159.1997.68031183.x · DOI · Paper page
- Rohan de Silva, 1997, Cell-specific expression of β-amyloid precursor protein isoform mRNAs and proteins in neurons and astrocytes, Brain Res. Mol. Brain Res., 47, 147, 10.1016/S0169-328X(97)00045-4 · DOI
- Li, 2010, Soluble amyloid precursor protein (APP) regulates transthyretin and Klotho gene expression without rescuing the essential function of APP, Proc. Natl. Acad. Sci. U.S.A., 107, 17362, 10.1073/pnas.1012568107 · DOI · Paper page
- Zheng, 1995, β-Amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity, Cell, 81, 525, 10.1016/0092-8674(95)90073-X · DOI · Paper page
- Köhler, 2005, Alzheimer disease-like neuropathology of gene-targeted APP-SLxPS1mut mice expressing the amyloid precursor protein at endogenous levels, Neurobiol. Dis., 20, 528, 10.1016/j.nbd.2005.04.009 · DOI · Paper page
- Xia, 2001, Loss of presenilin 1 is associated with enhanced β-catenin signaling and skin tumorigenesis, Proc. Natl. Acad. Sci. U.S.A., 98, 10863, 10.1073/pnas.191284198 · DOI · Paper page
- Lu, 2000, A second cytotoxic proteolytic peptide derived from amyloid β-protein precursor, Nat. Med., 6, 397, 10.1038/74656 · DOI · Paper page
- Bitner, 2010, Impact of arginase II on CBF in experimental cortical impact injury in mice using MRI, J. Cereb. Blood Flow. Metab., 30, 1105, 10.1038/jcbfm.2010.47 · DOI
- Shim, 2011, Disruption of the NF-κB/IκBα autoinhibitory loop improves cognitive performance and promotes hyperexcitability of hippocampal neurons, Mol. Neurodegener., 6, 42, 10.1186/1750-1326-6-42 · DOI
- Otsuka, 1991, Rapid appearance of β-amyloid precursor protein immunoreactivity in damaged axons and reactive glial cells in rat brain following needle stab injury, Brain Res., 568, 335, 10.1016/0006-8993(91)91422-W · DOI
- Li, 2010, Genetic dissection of the amyloid precursor protein in developmental function and amyloid pathogenesis, J. Biol. Chem., 285, 30598, 10.1074/jbc.M110.137729 · DOI
- Palmert, 1988, Antisera to an amino-terminal peptide detect the amyloid protein precursor of Alzheimer disease and recognize senile plaques, Biochem. Biophys. Res. Commun., 156, 432, 10.1016/S0006-291X(88)80859-3 · DOI
- Palmert, 1989, The β-amyloid protein precursor: mRNAs, membrane-associated forms, and soluble derivatives, Prog. Clin. Biol. Res., 317, 971
- Hyman, 1992, Kunitz protease inhibitor-containing amyloid β-protein precursor immunoreactivity in Alzheimer disease, J. Neuropathol. Exp. Neurol., 51, 76, 10.1097/00005072-199201000-00009 · DOI
- Shivers, 1988, Alzheimer disease amyloidogenic glycoprotein: expression pattern in rat brain suggests a role in cell contact, EMBO J., 7, 1365, 10.1002/j.1460-2075.1988.tb02952.x · DOI · Paper page
- Kaden, 2009, Subcellular localization and dimerization of APLP1 are strikingly different from APP and APLP2, J. Cell Sci., 122, 368, 10.1242/jcs.034058 · DOI
- Palacios, 1992, β-amyloid precursor protein localization in the Golgi apparatus in neurons and oligodendrocytes. An immunocytochemical structural and ultrastructural study in normal and axotomized neurons, Brain Res. Mol. Brain Res., 15, 195, 10.1016/0169-328X(92)90109-O · DOI
- Caporaso, 1994, Morphologic and biochemical analysis of the intracellular trafficking of the Alzheimer β/A4 amyloid precursor protein, J. Neurosci., 14, 3122, 10.1523/JNEUROSCI.14-05-03122.1994 · DOI · Paper page
- Benowitz, 1989, The amyloid precursor protein is concentrated in neuronal lysosomes in normal and Alzheimer disease subjects, Exp. Neurol., 106, 237, 10.1016/0014-4886(89)90156-8 · DOI
- Yang, 1998, The chaperone BiP/GRP78 binds to amyloid precursor protein and decreases Aβ40 and Aβ42 secretion, J. Biol. Chem., 273, 25552, 10.1074/jbc.273.40.25552 · DOI · Paper page
- Bai, 2008, The in vivo brain interactome of the amyloid precursor protein, Mol. Cell. Proteomics, 7, 15, 10.1074/mcp.M700077-MCP200 · DOI · Paper page
- Norstrom, 2010, Identification of NEEP21 as a β-amyloid precursor protein-interacting protein in vivo that modulates amyloidogenic processing in vitro, J. Neurosci., 30, 15677, 10.1523/JNEUROSCI.4464-10.2010 · DOI
- Yasuoka, 2004, Expression of amyloid precursor protein-like molecule in astroglial cells of the subventricular zone and rostral migratory stream of the adult rat forebrain, J. Anat., 205, 135, 10.1111/j.0021-8782.2004.00320.x · DOI
- Forloni, 1992, Expression of amyloid precursor protein mRNAs in endothelial, neuronal, and glial cells: modulation by interleukin-1, Brain Res. Mol. Brain Res., 16, 128, 10.1016/0169-328X(92)90202-M · DOI · Paper page
- Berkenbosch, 1990, The Alzheimer amyloid precursor protein is produced by type-I astrocytes in primary cultures of rat neuroglia, J. Neurosci. Res., 25, 431, 10.1002/jnr.490250321 · DOI
- Young, 1999, Intracellular and cell surface distribution of amyloid precursor protein in cortical astrocytes, Brain Res. Bull., 50, 27, 10.1016/S0361-9230(99)00084-2 · DOI
- Tran, 2011, P2 receptor stimulation induces amyloid precursor protein production and secretion in rat cortical astrocytes, Neurosci. Lett., 492, 155, 10.1016/j.neulet.2011.01.078 · doi:10.1016/j.neulet.2011.01.078
- Siman, 1989, Expression of β-amyloid precursor protein in reactive astrocytes following neuronal damage, Neuron, 3, 275, 10.1016/0896-6273(89)90252-3 · DOI · Paper page
- Palacios, 1995, Increased β-amyloid precursor protein expression in astrocytes in the gerbil hippocampus following ischemia: association with proliferation of astrocytes, Eur. J. Neurosci., 7, 501, 10.1111/j.1460-9568.1995.tb00346.x · DOI
- Martins, 2001, Altered expression of apolipoprotein E, amyloid precursor protein, and presenilin-1 is associated with chronic reactive gliosis in rat cortical tissue, Neuroscience, 106, 557, 10.1016/S0306-4522(01)00289-5 · DOI
- Nihashi, 2001, Expression and distribution of β-amyloid precursor protein and β-amyloid peptide in reactive astrocytes after transient middle cerebral artery occlusion, Acta Neurochir. (Wien.), 143, 287, 10.1007/s007010170109 · DOI
- Clarner, 2011, Glial amyloid precursor protein expression is restricted to astrocytes in an experimental toxic model of multiple sclerosis, J. Mol. Neurosci., 43, 268, 10.1007/s12031-010-9419-9 · DOI
- Solà, 1993, Increased levels of the Kunitz protease inhibitor-containing β-APP mRNAs in rat brain following neurotoxic damage, Brain Res. Mol. Brain Res., 17, 41, 10.1016/0169-328X(93)90071-V · DOI
- Moreno-Flores, 1998, βA amyloid peptide (25–35) induced APP expression in cultured astrocytes, J. Neurosci. Res., 52, 661, 10.1002/(SICI)1097-4547(19980615)52:6<661::AID-JNR5>3.0.CO;2-6 · doi:10.1002/(sici)1097-4547(19980615)52:6<661::aid-jnr5>3.0.co;2-6
- Matsui, 2007, Expression of APP pathway mRNAs and proteins in Alzheimer disease, Brain Res., 1161, 116, 10.1016/j.brainres.2007.05.050 · DOI · Paper page
- Szczygielski, 2005, Traumatic brain injury: cause or risk of Alzheimer disease? A review of experimental studies, J. Neural. Transm., 112, 1547, 10.1007/s00702-005-0326-0 · DOI
- Tran, 2011, Controlled cortical impact traumatic brain injury in 3×Tg-AD mice causes acute intra-axonal amyloid-β accumulation and independently accelerates the development of Tau abnormalities, J. Neurosci., 31, 9513, 10.1523/JNEUROSCI.0858-11.2011 · DOI · Paper page
- Zink, 2010, Emerging concepts in the pathophysiology of traumatic brain injury, Psychiatr. Clin. North Am., 33, 741, 10.1016/j.psc.2010.08.005 · DOI
- Shoji, 1990, Amyloid β-protein precursor accumulates in dystrophic neurites of senile plaques in Alzheimer-type dementia, Brain Res., 512, 164, 10.1016/0006-8993(90)91187-L · DOI
- Cras, 1991, Senile plaque neurites in Alzheimer disease accumulate amyloid precursor protein, Proc. Natl. Acad. Sci. U.S.A., 88, 7552, 10.1073/pnas.88.17.7552 · DOI · Paper page
- Cummings, 1992, Aggregation of the amyloid precursor protein within degenerating neurons and dystrophic neurites in Alzheimer disease, Neuroscience, 48, 763, 10.1016/0306-4522(92)90265-4 · DOI · Paper page
- Ni, 2011, Beyond the endoplasmic reticulum: atypical GRP78 in cell viability, signaling and therapeutic targeting, Biochem. J., 434, 181, 10.1042/BJ20101569 · DOI · Paper page
- Hoshino, 2007, Endoplasmic reticulum chaperones inhibit the production of amyloid-β-peptides, Biochem. J., 402, 581, 10.1042/BJ20061318 · DOI
- Hsu, 2008, Promoter polymorphisms modulating HSPA5 expression may increase susceptibility to Taiwanese Alzheimer disease, J. Neural. Transm., 115, 1537, 10.1007/s00702-008-0117-5 · DOI
Cited by
Not just amyloid: physiological functions of the amyloid precursor protein family
Müller, U. C., Deller, T., & Korte, M. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.29 · Cited by 634
Long, J. M., Ray, B., & Lahiri, D. K. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.366336 · Cited by 198
Woodruff, G., Reyna, S. M., Dunlap, M., Van Der Kant, R., Callender, J. A., Young, J. E., Roberts, E. A., & Goldstein, L. S. B. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.034 · Cited by 105
Sortilin and SorLA Display Distinct Roles in Processing and Trafficking of Amyloid Precursor Protein
Gustafsen, C., Glerup, S., Pallesen, L. T., Olsen, D., Andersen, O. M., Nykjær, A., Madsen, P., & Petersen, C. M. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.2371-12.2013 · Cited by 101
Ullah, R., Park, T. J., Huang, X., & Kim, M. O. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101451 · Cited by 78
Olsen, O., Kallop, D. Y., McLaughlin, T., Huntwork-Rodriguez, S., Wu, Z., Duggan, C. D., Simon, D. J., Lu, Y., Easley-Neal, C., Takeda, K., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.3522-13.2014 · Cited by 64
Niederst, E. D., Reyna, S. M., & Goldstein, L. S. B. (2015) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-06-1049 · Cited by 51
Tambini, M. D., Yao, W., & D'Adamio, L. (2019) · Aging Cell · doi:10.1111/acel.13033 · Cited by 40
“In the central nervous system, APP is mainly ex‐ pressed in neurons (Guo et al., 2012).”
BackgroundLee, Y., Lee, J. S., Lee, K. J., Turner, R. S., Hoe, H.-S., & Pak, D. T. S. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.02.027 · Cited by 27
Wang, J., Fourriere, L., & Gleeson, P. A. (2024) · Biochemical Journal · doi:10.1042/bcj20240056 · Cited by 27
Amyloid β production along the neuronal secretory pathway: Dangerous liaisons in the Golgi?
Fourriere, L., & Gleeson, P. A. (2021) · Traffic · doi:10.1111/tra.12808 · Cited by 25
Yesiltepe, M., Yin, T., Tambini, M. D., Breuillaud, L., Zehntner, S. P., & D’Adamio, L. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1040576 · Cited by 6
“In the CNS, APP is mainly expressed in neurons (Guo et al., 2012) and, in synapses, it is mainly found in synaptic vesicles (SV) (Groemer et al.”
Background
Metadata
- Authors
- Guo, Q., Li, H., Gaddam, S. S. K., Justice, N. J., Robertson, C. S., & Zheng, H.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2012-01
- Volume
- 287
- Issue
- 4
- Pages
- 2437-2445
- ISSN
- 0021-9258
- Cited by
- 94
- References
- 3
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 3180 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.